Merck KGaA (OTCMKTS:MKKGY) Releases Earnings Results

Merck KGaA (OTCMKTS:MKKGY) announced its earnings results on Wednesday. The company reported $0.59 earnings per share for the quarter, topping analysts’ consensus estimates of $0.45 by $0.14, Zacks reports. Merck KGaA had a net margin of 12.07% and a return on equity of 8.93%. The company had revenue of $6.03 billion during the quarter, compared to the consensus estimate of $5.93 billion.

Merck KGaA Stock Down 2.8%

Shares of MKKGY stock traded down $0.79 during trading hours on Friday, hitting $27.29. 25,348 shares of the company were exchanged, compared to its average volume of 118,574. The business has a 50 day moving average of $25.96 and a two-hundred day moving average of $27.55. The company has a current ratio of 1.46, a quick ratio of 0.96 and a debt-to-equity ratio of 0.37. Merck KGaA has a 52 week low of $23.73 and a 52 week high of $31.00. The company has a market capitalization of $17.64 billion, a PE ratio of 12.13, a PEG ratio of 2.58 and a beta of 0.97.

Analyst Upgrades and Downgrades

MKKGY has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft downgraded shares of Merck KGaA from a “buy” rating to a “hold” rating in a research note on Tuesday, February 3rd. Sanford C. Bernstein raised shares of Merck KGaA to a “hold” rating in a research note on Thursday, March 19th. Four research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Merck KGaA has a consensus rating of “Hold”.

Merck KGaA Company Profile

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.